The association between low muscle mass and sarcopenic obesity, survival, and major complications in patients with advanced ovarian cancer undergoing primary cytoreductive surgery: A retrospective study
European Journal of Surgical Oncology · 2025
DOI: 10.1016/j.ejso.2025.110286 ↗Kurz gefasst
Fachartikel in der Zeitschrift European Journal of Surgical Oncology, 2025. Verfasst von Niina Norppa und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Obstetrics and Gynecology, Tampere University Hospital, Tampere, Finland; Tays Cancer Centre, Tampere University Hospital, Tampere, Fin…. Hauptthemen laut MEDLINE: Sarcopenia, Ovarian Neoplasms, Cytoreduction Surgical Procedures, Obesity. Die Arbeit nennt 31 Literaturangaben.
Abstract (Originalsprache)
OBJECTIVE: The aim of this study is to determine whether imaging-derived estimates of muscle mass or sarcopenic obesity are associated with survival and surgery-related complications in patients with advanced epithelial ovarian cancer treated with primary cytoreductive surgery (PCS). METHODS: A skeletal muscle index (SMI) was determined by normalizing the muscle area at the level of third lumbar vertebra with the patient's height. Patients with SMI 25 kg/m2 were deemed to be affected by sarcopenic obesity. The relationships between low SMI and sarcopenic obesity, 1-year, 3-year, and overall survival were studied with Cox regression and Kaplan-Meier methods. The effect of SMI and sarcopenic obesity on surgery-related major complications (Clavien-Dindo ≥ IIIB) was studied with logistic regression models. RESULTS: Ninety-two patients were retrospectively included, of whom 35 (38.0 %) and 12 (13.0 %) had low muscle mass or were affected by sarcopenic obesity, respectively. Among 73 (79.3 %) patients with high-grade serous OC, the 1-year survival rates were 66.7 % and 95.3 % (hazard ratio [HR] 9.19 [95 % confidence interval (CI): 1.85-45.75]) and the 3-year survival rates were 58.3 % and 68.8 % (HR 2.95 [95 % CI: 1.10-7.92]) for patients with and without sarcopenic obesity, respectively. Neither low muscle mass nor sarcopenic obesity was associated with major complications. CONCLUSION: Sarcopenic obesity was a marker of poor 1-year and 3-year survival in patients with high-grade serous OC. Neither low muscle mass nor sarcopenic obesity was associated with major complications in PCS.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Obstetrics and Gynecology, Tampere University Hospital, Tampere, Finland; Tays Cancer Centre, Tampere University Hospital, Tampere, Finland; Faculty of Medicine and Health Technology, Tampere University, T…
- Faculty of Medicine and Health Technology, Tampere University, Tampere, Finland; Department of Radiology, Tampere University Hospital, Tampere, Finland.
- Department of Obstetrics and Gynecology, Kuopio University Hospital, Kuopio, Finland; Institute of Clinical Medicine, University of Eastern Finland, Kuopio, Finland.
- Department of Obstetrics and Gynecology, Tampere University Hospital, Tampere, Finland; Tays Cancer Centre, Tampere University Hospital, Tampere, Finland.
- Tays Cancer Centre, Tampere University Hospital, Tampere, Finland; Faculty of Medicine and Health Technology, Tampere University, Tampere, Finland; Institute of Clinical Medicine, University of Eastern Finland, Kuopio,…
Zitieren
APA
Norppa, N., Tolonen, A., Reijonen, M., Lindgren, A., Staff, S., Rinta-Kiikka, I., Saarelainen, S., & Arponen, O. (2025). The association between low muscle mass and sarcopenic obesity, survival, and major complications in patients with advanced ovarian cancer undergoing primary cytoreductive surgery: A retrospective study. European Journal of Surgical Oncology. https://doi.org/10.1016/j.ejso.2025.110286
Vancouver
Norppa N, Tolonen A, Reijonen M, Lindgren A, Staff S, Rinta-Kiikka I, et al. The association between low muscle mass and sarcopenic obesity, survival, and major complications in patients with advanced ovarian cancer undergoing primary cytoreductive surgery: A retrospective study. European Journal of Surgical Oncology. 2025. doi:10.1016/j.ejso.2025.110286
BibTeX
@article{Norppa2025,
author = {Norppa, Niina and Tolonen, Antti and Reijonen, Milja and Lindgren, Auni and Staff, Synnöve and Rinta-Kiikka, Irina and Saarelainen, Sami and Arponen, Otso},
title = {The association between low muscle mass and sarcopenic obesity, survival, and major complications in patients with advanced ovarian cancer undergoing primary cytoreductive surgery: A retrospective study},
journal = {European Journal of Surgical Oncology},
year = {2025},
doi = {10.1016/j.ejso.2025.110286}
}
EUVIMED